• Mon news: Novartis Kisqali breast cancer trial. ESMO news: Bayer, Bristol Myers, Regeneron and more. Biosecure Act fallout. Boston Scientific/Silk Road merger. See more on our front page

Wake up. More layoffs to come if they don’t run everyone off before

anonymous

Guest
This is a joke, so many people still interviewing, others in the final interview and takeda in so much debt that they are fucked. I can’t wait to get out of this shit show as I was hoping to get cut. Speciality with large territories, and general medicine with me2 drugs. Get out while you can as I’m trying as hard as I can. The only problem is that I’m with takeda and everyone with success is in a true speciality. Not vyvanse. What a joke this has become. Please make another. Cut soon.